Lenders JWM, Duh QY, Eisenhofer G, Gimenez-Roqueplo AP, Grebe SKG, Murad MH et al (2014) Pheochromocytoma and Paraganglioma: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 99(6):1915–1942. https://doi.org/10.1210/jc.2014-1498

Article  CAS  PubMed  Google Scholar 

Berends AMA, Buitenwerf E, De Krijger RR, Veeger NJGM, Van Der Horst-Schrivers ANA, Links TP et al (2018) Incidence of pheochromocytoma and sympathetic paraganglioma in the Netherlands: A nationwide study and systematic review. Eur J Intern Med 51:68–73. https://doi.org/10.1016/j.ejim.2018.01.015

Article  PubMed  Google Scholar 

Pacak K (2022) New Biology of Pheochromocytoma and Paraganglioma. Endocr Pract 28(12):1253–1269. https://doi.org/10.1016/j.eprac.2022.09.003

Article  PubMed  PubMed Central  Google Scholar 

Eisenhofer G, Pacak K, Huynh TT, Qin N, Bratslavsky G, Linehan WM et al (2010) Catecholamine metabolomic and secretory phenotypes in phaeochromocytoma. Endocr Relat Cancer 18(1):97–111. https://doi.org/10.1677/ERC-10-0211

Article  CAS  PubMed  PubMed Central  Google Scholar 

Klabunde RE (2012) Neurohumoral Control of the Heart and Circulation. Cardiovascular Physiology Concepts. Lippincott Williams and Wilkins, pp 117–139

Santos JRU, Brofferio A, Viana B, Pacak K (2019) Catecholamine-Induced Cardiomyopathy in Pheochromocytoma: How to Manage a Rare Complication in a Rare Disease? Horm Metab Res 51(07):458–469. https://doi.org/10.1055/a-0669-9556

Article  CAS  PubMed  Google Scholar 

Y-Hassan S, Falhammar H (2020) Cardiovascular Manifestations and Complications of Pheochromocytomas and Paragangliomas. JCM 9(8):2435. https://doi.org/10.3390/jcm9082435

Article  CAS  PubMed  PubMed Central  Google Scholar 

Group PRISMA-P, Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A et al (2015) Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev 4(1):1. https://doi.org/10.1186/2046-4053-4-1

Article  Google Scholar 

Kakargia E, Tsentidis C, Mantzouranis E, Kanti G, Fountas A, Markou A, Papanastasiou L (2024) Catecholamine-induced cardiovascular complications in patients diagnosed with pheochromocytoma or paraganglioma: are there prognostic factors? A systematic review and meta- analysis. PROSPERO CRD42024550621. Available from: https://www.crd.york.ac.uk/PROSPERO/view/CRD42024550621

Dignen B (2008) Undertaking systematic reviews of research on effectiveness. York Associates International, York, p 8

Google Scholar 

Moher D, Liberati A, Tetzlaff J, Altman DG, for the PRISMA Group (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 339(jul21 1):b2535–b2535. https://doi.org/10.1136/bmj.b2535

Article  PubMed  PubMed Central  Google Scholar 

Stroup DF (2000) Meta-analysis of Observational Studies in EpidemiologyA Proposal for Reporting. JAMA 283(15):2008. https://doi.org/10.1001/jama.283.15.2008

Article  CAS  PubMed  Google Scholar 

Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25(9):603–605

Article  PubMed  Google Scholar 

Bai S, Yao Z, Zhu X, Li Z, Jiang Y, Wang R et al (2019) Risk factors for postoperative cardiovascular morbidity after pheochromocytoma surgery: a large single center retrospective analysis. Endocr J 66(2):165–173. https://doi.org/10.1507/endocrj.EJ18-0402

Article  CAS  PubMed  Google Scholar 

Zhou J, Xuan H, Miao Y, Hu J, Dai Y (2021) Acute cardiac complications and subclinical myocardial injuries associated with pheochromocytoma and paraganglioma. BMC Cardiovasc Disord 21(1):203. https://doi.org/10.1186/s12872-021-02013-6

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zelinka T, Petrák O, Turková H, Holaj R, Štrauch B, Kršek M et al (2012) High Incidence of Cardiovascular Complications in Pheochromocytoma. Horm Metab Res 44(05):379–384. https://doi.org/10.1055/s-0032-1306294

Article  CAS  PubMed  Google Scholar 

Yu Y, Chen C, Han W, Zhang Y, Zhang Z, Yang Y (2022) Metanephrine and normetanephrine associated with subclinical myocardial injuries in pheochromocytoma and paraganglioma. Front Oncol 12:1024342. https://doi.org/10.3389/fonc.2022.1024342

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yu R, Nissen NN, Bannykh SI (2012) Cardiac Complications as Initial Manifestation of Pheochromocytoma: Frequency, Outcome, and Predictors. Endocr Pract 18(4):483–492. https://doi.org/10.4158/EP11327.OR

Article  PubMed  Google Scholar 

Wang Y, Yu X, Huang Y (2022) Predictive Factors for Catecholamine-Induced Cardiomyopathy in Patients with Pheochromocytoma and Paraganglioma. Front Endocrinol 13:853878. https://doi.org/10.3389/fendo.2022.853878

Article  Google Scholar 

Riester A, Weismann D, Quinkler M, Lichtenauer UD, Sommerey S, Halbritter R et al (2015) Life-threatening events in patients with pheochromocytoma. Eur J Endocrinol 173(6):757–764. https://doi.org/10.1530/EJE-15-0483

Article  CAS  PubMed  Google Scholar 

Petrák O, Krátká Z, Holaj R, Zítek M, Nguyen Nikrýnová T, Klímová J et al (2024) Cardiovascular Complications in Pheochromocytoma and Paraganglioma: Does Phenotype Matter? Hypertension. 81(3):595–603. https://doi.org/10.1161/HYPERTENSIONAHA.123.21902

Giavarini A, Chedid A, Bobrie G, Plouin PF, Hagège A, Amar L (2013) Acute catecholamine cardiomyopathy in patients with phaeochromocytoma or functional paraganglioma. Heart 99(19):1438–1444. https://doi.org/10.1136/heartjnl-2013-304073

Article  PubMed  Google Scholar 

Rzepka E, Kokoszka J, Grochowska A, Ulatowska-Białas M, Lech M, Opalińska M et al (2022) Adrenal bleeding due to pheochromocytoma - A call for algorithm. Front Endocrinol 13:908967. https://doi.org/10.3389/fendo.2022.908967

Article  Google Scholar 

Xu M, Guan Q, Liu T, Huang Y, Pan C, Luo L et al (2024) In-Hospital Adverse Events of Pheochromocytoma-Induced Takotsubo Syndrome: A Literature Review and Cluster Analysis of 172 Cases. Rev Cardiovasc Med 25(6):216. https://doi.org/10.31083/j.rcm2506216

Article  PubMed  PubMed Central  Google Scholar 

Aw A, De Jong MC, Varghese S, Lee J, Foo R, Parameswaran R (2023) A systematic cohort review of pheochromocytoma-induced typical versus atypical Takotsubo cardiomyopathy. Int J Cardiol 371:287–292. https://doi.org/10.1016/j.ijcard.2022.08.053

Article  PubMed  Google Scholar 

Cuspidi C, Gherbesi E, Faggiano A, Sala C, Carugo S, Grassi G et al (2023) Targeting Left Ventricular Mechanics In Patients With Pheochromocytoma/Paraganglioma: An Updated Meta-analysis. Am J Hypertens 36(6):333–340. https://doi.org/10.1093/ajh/hpad006

Article  PubMed  PubMed Central  Google Scholar